Run the checker

State filing guide

CLIA waiver application and requirements in Oregon.

Ask about my application — no payment today

Oregon routes ordinary clinical waived testing through CMS-116 to OSPHL Laboratory Compliance; the May 2026 amendments remove the obsolete separate clinical-license program and its fees.

Sources checked 2026-11-12 · next source check due 2026-12-12

Federal application procedure

These findings describe the linked sources. They do not establish that your facility qualifies for an exemption or that its application is ready. Facility type, ownership, personnel, locations and exact test systems can change the requirements.

Have your Oregon CLIA waiver application prepared for you — US$195

We check each test you plan to run, prepare your Oregon CMS-116 ready to sign, and give you signature and filing instructions. If our check shows that you do not need a certificate, or we cannot take your case, we refund the US$195 in full. Leave your email and we will send you the details and the payment link.

Request for Oregon price and payment link

Business details only. Do not enter patient information or government identifiers.

What the official sources say

  • OHA states that a laboratory with the required CLIA certificate does not need a separate OHA clinical laboratory license. The May 21, 2026 amendments removed the ordinary clinical-license fee. Special Health Screen Testing, substance-of-abuse and other nonordinary activities require separate review. Written orders, professional authority, safety, waste and reporting duties remain applicable.
  • Oregon Health Authority, Oregon State Public Health Laboratory, Laboratory Compliance Section; LC.info@odhsoha.oregon.gov; fax 503-693-5602; 7202 NE Evergreen Parkway, Suite 100, Hillsboro, OR 97124-6536. OHA acknowledges emailed/faxed forms and asks that duplicate hard copies not follow. A human confirms accepted initial signature/packet requirements, obtains client authorization and retains delivery evidence.
  • Form CMS-116 (04/2026), OMB expiration 04/30/2029, mandatory revised edition from November 9, 2026. For initial Certificate of Waiver, leave the initial CLIA number blank, select Waiver, complete sections 1-6 and 9-10, identify exact test systems and annual volumes, and obtain the laboratory director, owner or authorized representative signature. Include every applicable application page, including the signature on printed page 6 (physical PDF sheet 7). Record a monitored business email for mandatory electronic CMS communications. No payment with the application; retain any state-specific enclosures listed separately.
  • Report all blood lead results to OHA within seven working days; results at least 3.5 micrograms/dL within one working day. Use secure reporting, including fax 971-673-0457 where applicable, never unsecure email. For LeadCare II, report Low as less than 3.3 micrograms/dL, not zero. Establish reporting enrollment/form workflow and venous confirmation; no separate analyzer permit was identified, but its absence was not expressly certified. Retain authorized test ordering, safety/waste and reporting-log requirements. Blood lead is confirmed case by case with the reviewer and quoted separately in writing after review.

Fees and timing

Federal Certificate of Waiver: $248 per two-year certificate, paid through Pay.gov after the electronic CMS fee coupon and CLIA ID. No payment with CMS-116 and no paper checks. Government fees are separate from WaivedLab preparation-service fees. Begin testing only after receiving the certificate; no processing or approval date is promised. OHA states that a laboratory with the required CLIA certificate does not need a separate OHA clinical laboratory license. The May 21, 2026 amendments removed the ordinary clinical-license fee. Special Health Screen Testing, substance-of-abuse and other nonordinary activities require separate review. Written orders, professional authority, safety, waste and reporting duties remain applicable.

Check my test menu

What still needs confirmation for your facility

  1. 1Confirm an initial, fixed, single-site office testing only its own patients with exact unmodified waived systems; review other facility types, outside referrals, mobile/multisite, PPM and non-waived testing separately.
  2. 2Before filing, review and sign the completed packet, confirm the accepted submission method and authorize submission; retain delivery evidence. Resolve any additional requirements for your facility before filing.
  3. 3Will this site perform on-site blood lead testing? Confirm reporting enrollment, deadlines, exact waived use, venous confirmation/referral and any personnel, analyzer or reimbursement duties case by case with the reviewer before including blood lead.

Frequently asked questions

What filing route does the cited Oregon guidance describe?

Oregon routes ordinary clinical waived testing through CMS-116 to OSPHL Laboratory Compliance; the May 2026 amendments remove the obsolete separate clinical-license program and its fees.

Which requirements are named in the cited Oregon materials?

OHA states that a laboratory with the required CLIA certificate does not need a separate OHA clinical laboratory license. The May 21, 2026 amendments removed the ordinary clinical-license fee. Special Health Screen Testing, substance-of-abuse and other nonordinary activities require separate review. Written orders, professional authority, safety, waste and reporting duties remain applicable. Oregon Health Authority, Oregon State Public Health Laboratory, Laboratory Compliance Section; LC.info@odhsoha.oregon.gov; fax 503-693-5602; 7202 NE Evergreen Parkway, Suite 100, Hillsboro, OR 97124-6536. OHA acknowledges emailed/faxed forms and asks that duplicate hard copies not follow. A human confirms accepted initial signature/packet requirements, obtains client authorization and retains delivery evidence. Form CMS-116 (04/2026), OMB expiration 04/30/2029, mandatory revised edition from November 9, 2026. For initial Certificate of Waiver, leave the initial CLIA number blank, select Waiver, complete sections 1-6 and 9-10, identify exact test systems and annual volumes, and obtain the laboratory director, owner or authorized representative signature. Include every applicable application page, including the signature on printed page 6 (physical PDF sheet 7). Record a monitored business email for mandatory electronic CMS communications. No payment with the application; retain any state-specific enclosures listed separately. Report all blood lead results to OHA within seven working days; results at least 3.5 micrograms/dL within one working day. Use secure reporting, including fax 971-673-0457 where applicable, never unsecure email. For LeadCare II, report Low as less than 3.3 micrograms/dL, not zero. Establish reporting enrollment/form workflow and venous confirmation; no separate analyzer permit was identified, but its absence was not expressly certified. Retain authorized test ordering, safety/waste and reporting-log requirements. Blood lead is confirmed case by case with the reviewer and quoted separately in writing after review.

What do the sources establish about fees and timing in Oregon?

Federal Certificate of Waiver: $248 per two-year certificate, paid through Pay.gov after the electronic CMS fee coupon and CLIA ID. No payment with CMS-116 and no paper checks. Government fees are separate from WaivedLab preparation-service fees. Begin testing only after receiving the certificate; no processing or approval date is promised. OHA states that a laboratory with the required CLIA certificate does not need a separate OHA clinical laboratory license. The May 21, 2026 amendments removed the ordinary clinical-license fee. Special Health Screen Testing, substance-of-abuse and other nonordinary activities require separate review. Written orders, professional authority, safety, waste and reporting duties remain applicable.

Does this page confirm CLIA approval or legal compliance in Oregon?

No. This is an educational prep checklist. It does not confirm approval, legal compliance, or waived status for any specific device. Verify every requirement with CMS, the FDA, and your state agency before testing.

Other jurisdictions

Each jurisdiction publishes its own terminology, forms, channel, signatures, and fees.

All 52jurisdictions →

Need help with your Oregon CLIA route?

Tell us where your clinic operates and what you need to prepare or change. You can ask before you know your exact test system. We review the next facts needed before proposing any paid scope.

Request a scope inquiry — no payment today

Business inquiries only. Do not send patient information, test results, dates of birth, government identifiers, credential numbers, or documents.

Initial business inquiry

From test research to your Oregon application

An analyte label does not confirm a device. The exact test system and the clinic’s state route need separate review before a filing scope or price can be confirmed.